Have you or your loved ones been diagnosed with advanced solid tumors cancer?

You may be eligible to participate in a advanced solid tumors cancer clinical trial.

Have you or your loved ones been diagnosed with advanced solid tumors cancer? You may be eligible to participate in a advanced solid tumors cancer clinical trial.

What is a clinical trial? Is participating in a clinical trial right for you? Learn more

Advanced Solid Tumors Cancer Clinical Trial
NCT03071757 | Phase 1 | Interventional
AbbVie
Sponsored by
AbbVie

Have you or your loved ones been diagnosed with advanced solid tumors cancer?

You may be eligible to participate in a advanced solid tumors cancer clinical trial.

Have you or your loved ones been diagnosed with advanced solid tumors cancer? You may be eligible to participate in a advanced solid tumors cancer clinical trial.

Completed

Male & Female

18 Years +

This study has recruited 139 Participants

The primary purpose of this Phase 1, open-label study is to evaluate the safety, pharmacokinetics, and preliminary efficacy of ABBV-368 as a monotherapy and in combination with ABBV-181 in participants with locally advanced or metastatic solid tumors. The study will consist of 3 parts: ABBV-368 dose escalation, ABBV-368 tumor-specific dose expansion (triple negative breast cancer [TNBC] cohort and head and neck cancer cohort) and 18F-AraG Imaging Substudy.